Should I Buy PMVP? PMVP 2026 Analysis

Should You Buy PMV Pharmaceuticals Inc (PMVP) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

1.220

1 Day change

0.83%

52 Week Range

1.840

Analysis Updated At

2026/01/26

PMV Pharmaceuticals Inc (PMVP) is not a strong buy for a beginner, long-term investor at this time. The technical indicators suggest a bearish trend, and there are no significant positive catalysts or strong financial performance to support a buy decision. While hedge funds are buying, the lack of insider activity, weak financials, and absence of recent news or analyst upgrades make this stock a hold for now.

Technical Analysis

The technical indicators show a bearish trend. The MACD histogram is below 0 and negatively contracting, the RSI is neutral at 58.145, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 1.136, with resistance at 1.201 and support at 1.071.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

Hedge funds are buying significantly, with a 2450.33% increase in buying activity over the last quarter.

Neutral/Negative Catalysts

No recent news, no insider buying activity, and no significant congress trading data. The financial performance is weak, with no revenue and a net loss of -$21.06M in Q3 2025.

Financial Performance

In Q3 2025, the company reported no revenue growth (0% YoY), a net loss of -$21.06M (up 9.53% YoY), and an EPS of -0.4 (up 8.11% YoY). Gross margin remains at 0%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes available.

4 Analyst Rating

Wall Street analysts forecast PMVP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PMVP is 5 USD with a low forecast of 4 USD and a high forecast of 6 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

0 Hold

0 Sell

Strong Buy

Current: 1.210

Low

Averages

High

Current: 1.210

Low

Averages

High

HC Wainwright & Co.

Robert Burns

Strong Buy

Reiterates

AI Analysis

2025-03-20

Reason

HC Wainwright & Co.

Robert Burns

Price Target

AI Analysis

2025-03-20

Reiterates

Strong Buy

Reason

PMVP Should I Buy

PMVP Should I Buy

Should You Buy PMV Pharmaceuticals Inc (PMVP) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch